August 2004 Cover
|
 |
Increases in fluoroquinolone-resittant gonorrhea among gay and bisexual men have led CDC to change gonorrhea treatment recommendations for some patients, the agency announced last month. All men who are diagnosed with gonorrhea and who acknowledge having sex with
other men-- whether or not they self-identify as gay-- should now receive the injectable antibiotic drug ceftriaxone for treatment instead of fluoroquinolone antibiotics including ciprofloxacin (Cipro) and ofloxaxin. Fluoroquinolone-resistant gonorrhea is common in Asia and England, and
it appeared in Hawaii and California in recent years, CDC officials said. Between 2001-2003, resistant gonorrhea was found in a survey of 30 US cities, accounting for 4.9 percent of cases among gay and bisexual men and 0.4 percent among heterosexuals.
CDC believes the strain arrived from Asia via men who had sex abroad, and it then spread to other men through tight social networks on the West Coast, said Dr. John Douglas, director of CDC's STD prevention programs.
from the Atlanta Journal Constitution
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|
